Here’s What Jim Cramer Thinks About Consolidation in Pharma and Health Care
Jim Cramer expects to see more deal activity in the pharmaceuticals space.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer expects to see more deal activity in the pharmaceuticals space. 'Allergan (AGN) - Get Report is going to get the money soon from Teva (TEVA) - Get Report soon,' Cramer said, referring to Teva's recent $40 billion acquisition of Allergan Generics. Allergan is a holding of Cramer's charitable trust, Action Alerts PLUS.
At the time of publication, Jim Cramer's charitable trust Action Alerts PLUS held no positions in stocks mentioned.
